Draft Guidance Issued on BiMo PMA Applications, Inspections

International Medical Device Regulatory Monitor
KEYWORDS BIMO / Regulations
A A

The FDA published draft guidance June 20 to help devicemakers understand the process for the review of clinical and nonclinical information in premarket approval (PMA) applications and related inspections under the bioresearch monitoring (BiMo) program.

To View This Article:

Login

Subscribe To International Medical Device Regulatory Monitor

Buy This Article Now

Add this article to your cart for $10.00